Supplementary data.docx (149.04 kB)

Supplementary data: Galantamine nanoparticles outperform oral galantamine in an Alzheimer’s rat model: pharmacokinetics and pharmacodynamics.docx

figure

posted on 2021-05-20, 10:44 authored by Samar Ossama El-Ganainy, Mennatallah Adel Gowayed, Mahmoud Agami, Passant Mohamed, Marwa Belal, Ragwa Mohamed Farid, Amira Sayed Hanafy

Supplementary Data 1.

Funding

This study was financially supported by the Academy of Scientific Research and Technology (ASRT), Egypt, under the ‘Egypt Knowledge and technology Alliances (EG-KTA) program’ (ID, KTA-C2-2.10)

History

Usage metrics

Keywords

Chitosan nanoparticles galantamine Alzheimer’s disease Nose-to-Brain delivery cognitive impairment pharmacokinetics Neurology and Neuromuscular Diseases

Licence

CC BY-NC-ND 4.0